Literature DB >> 19408105

A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.

Torsten Stein1, Nathan Salomonis, Dimitry S A Nuyten, Marc J van de Vijver, Barry A Gusterson.   

Abstract

Mouse mammary gland involution resembles a wound healing response with suppressed inflammation. Wound healing and inflammation are also associated with tumour development, and a 'wound-healing' gene expression signature can predict metastasis formation and survival. Recent studies have shown that an involuting mammary gland stroma can promote metastasis. It could therefore be hypothesised that gene expression signatures from an involuting mouse mammary gland may provide new insights into the physiological pathways that promote breast cancer progression. Indeed, using the HOPACH clustering method, the human orthologues of genes that were differentially regulated at day 3 of mammary gland involution and showed prolonged expression throughout the first 4 days of involution distinguished breast cancers in the NKI 295 breast cancer dataset with low and high metastatic activity. Most strikingly, genes associated with copper ion homeostasis and with HIF-1 promoter binding sites were the most over-represented, linking this signature to hypoxia. Further, six out of the ten mRNAs with strongest up-regulation in cancers with poor survival code for secreted factors, identifying potential candidates that may be involved in stromal/matrix-enhanced metastasis formation/breast cancer development. This method therefore identified biological processes that occur during mammary gland involution, which may be critical in promoting breast cancer metastasis that could form a basis for future investigation, and supports a role for copper in breast cancer development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19408105     DOI: 10.1007/s10911-009-9120-1

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  109 in total

1.  Essential role for Atox1 in the copper-mediated intracellular trafficking of the Menkes ATPase.

Authors:  Iqbal Hamza; Joseph Prohaska; Jonathan D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

2.  Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis.

Authors:  Shauntae M McDaniel; Kristen K Rumer; Sandra L Biroc; Richard P Metz; Meenakshi Singh; Weston Porter; Pepper Schedin
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells.

Authors:  J Yoshii; H Yoshiji; S Kuriyama; Y Ikenaka; R Noguchi; H Okuda; H Tsujinoue; T Nakatani; H Kishida; D Nakae; D E Gomez; M S De Lorenzo; A M Tejera; H Fukui
Journal:  Int J Cancer       Date:  2001-12-15       Impact factor: 7.396

Review 4.  The great escape: when cancer cells hijack the genes for chemotaxis and motility.

Authors:  John Condeelis; Robert H Singer; Jeffrey E Segall
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

5.  Serum trace elements and Cu/Zn ratio in breast cancer patients.

Authors:  S K Gupta; V K Shukla; M P Vaidya; S K Roy; S Gupta
Journal:  J Surg Oncol       Date:  1991-03       Impact factor: 3.454

6.  Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.

Authors:  Jean-Philippe Dales; Stéphane Garcia; Séverine Meunier-Carpentier; Lucile Andrac-Meyer; Olivier Haddad; Marie-Noölle Lavaut; Claude Allasia; Pascal Bonnier; Colette Charpin
Journal:  Int J Cancer       Date:  2005-09-20       Impact factor: 7.396

7.  Angiopoietin-like-4 is a potential angiogenic mediator in arthritis.

Authors:  L M Hermann; M Pinkerton; K Jennings; L Yang; A Grom; D Sowders; S Kersten; D P Witte; R Hirsch; S Thornton
Journal:  Clin Immunol       Date:  2005-04       Impact factor: 3.969

8.  Integrin beta4 signaling promotes tumor angiogenesis.

Authors:  Sotiris N Nikolopoulos; Pamela Blaikie; Toshiaki Yoshioka; Wenjun Guo; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2004-11       Impact factor: 31.743

9.  Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression.

Authors:  Richard W E Clarkson; Matthew T Wayland; Jennifer Lee; Tom Freeman; Christine J Watson
Journal:  Breast Cancer Res       Date:  2003-12-18       Impact factor: 6.466

10.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029

View more
  29 in total

Review 1.  Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?

Authors:  Virginia F Borges; Traci R Lyons; Doris Germain; Pepper Schedin
Journal:  Cancer Res       Date:  2020-02-19       Impact factor: 12.701

2.  Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.

Authors:  Jamie C Stanford; Christian Young; Donna Hicks; Philip Owens; Andrew Williams; David B Vaught; Meghan M Morrison; Jiyeon Lim; Michelle Williams; Dana M Brantley-Sieders; Justin M Balko; Debra Tonetti; H Shelton Earp; Rebecca S Cook
Journal:  J Clin Invest       Date:  2014-09-24       Impact factor: 14.808

Review 3.  Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

Authors:  Jaime Fornetti; Holly A Martinson; Courtney B Betts; Traci R Lyons; Sonali Jindal; Qiuchen Guo; Lisa M Coussens; Virginia F Borges; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-22       Impact factor: 2.673

4.  Transcriptomic profiles of the bovine mammary gland during lactation and the dry period.

Authors:  Wen-Ting Dai; Yi-Xuan Zou; Robin R White; Jian-Xin Liu; Hong-Yun Liu
Journal:  Funct Integr Genomics       Date:  2017-12-23       Impact factor: 3.410

5.  Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology.

Authors:  Jonine D Figueroa; Ruth M Pfeiffer; Deesha A Patel; Laura Linville; Louise A Brinton; Gretchen L Gierach; Xiaohong R Yang; Daphne Papathomas; Daniel Visscher; Carolyn Mies; Amy C Degnim; William F Anderson; Stephen Hewitt; Zeina G Khodr; Susan E Clare; Anna Maria Storniolo; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-10-01       Impact factor: 13.506

6.  Physiologically activated mammary fibroblasts promote postpartum mammary cancer.

Authors:  Qiuchen Guo; Jessica Minnier; Julja Burchard; Kami Chiotti; Paul Spellman; Pepper Schedin
Journal:  JCI Insight       Date:  2017-03-23

7.  Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue--influence of a modulated host stroma on the prognosis of HCC.

Authors:  Frank Simon; Maximilian Bockhorn; Christian Praha; Hideo A Baba; Christoph E Broelsch; Andrea Frilling; Frank Weber
Journal:  Langenbecks Arch Surg       Date:  2010-02-18       Impact factor: 3.445

8.  Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells.

Authors:  Colleen S Curran; Esteban R Carrillo; Suzanne M Ponik; Patricia J Keely
Journal:  Environ Toxicol Pharmacol       Date:  2014-11-01       Impact factor: 4.860

Review 9.  Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice.

Authors:  Christine B Ambrosone; Michael J Higgins
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

10.  CCAAT-enhancer binding protein delta (C/EBPδ) attenuates tubular injury and tubulointerstitial fibrogenesis during chronic obstructive nephropathy.

Authors:  JanWillem Duitman; Keren S Borensztajn; Willem P C Pulskens; Jaklien C Leemans; Sandrine Florquin; C Arnold Spek
Journal:  Lab Invest       Date:  2013-11-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.